Delaware Judge Axes Novartis Patent On Heart Failure Drug

By Ryan Davis · July 7, 2023, 9:01 PM EDT

A Delaware federal judge ruled Friday that a patent covering Entresto, a blockbuster heart failure drug made by Novartis, is invalid for lacking an adequate written description, handing a win to...

To view the full article, register now.

Documents

Case Information

Case Title

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

Case Number

1:20-md-02930

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

March 27, 2020